Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

927
This protocol presents a step-by-step guide for performing minimally invasive isolated limb perfusion (MI-ILP), a treatment option for patients with locally advanced melanomas and sarcomas of the...
927
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

905
Here, a protocol for designing, constructing, and delivering tetracycline-controlled based inducible synthetic circuit is presented. The effect of the synthetic circuits on parasite elimination and cytokine expression can be studied by channelizing the presented pipeline. This protocol is relevant for researchers studying synthetic circuit-based therapeutics in infectious...
905
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

2.8K
This article describes a workflow of techniques employed for testing novel candidate mediators of melanoma metastasis and their mechanism(s) of action.
2.8K
Advances in Nanoscale Infrared Spectroscopy to Explore Multiphase Polymeric Systems06:54

Advances in Nanoscale Infrared Spectroscopy to Explore Multiphase Polymeric Systems

1.3K
This protocol describes the application of atomic force microscopy and nanoscale infrared spectroscopy to evaluate the performance of photothermal nanoscale infrared spectroscopy in the characterization of three-dimensional multi-polymeric samples.
1.3K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

13.1K
Patient-derived xenograft (PDX) models more robustly recapitulate melanoma molecular and biological features and are more predictive of therapy response compared to traditional plastic tissue culture-based assays. Here we describe our standard operating protocol for the establishment of new PDX models and the characterization/experimentation of existing PDX...
13.1K
Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies12:38

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

6.6K
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of p16, p21, and PRAME Immunohistochemistry in Melanocytic Lesions.

The American Journal of dermatopathology·2026
Same author

Mohs Micrographic Surgery for Penile Squamous Cell Carcinoma: A Systematic Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Chronic Painful Vegetative Plaques on the Buttocks: Answer.

The American Journal of dermatopathology·2024
Same author

Chronic Painful Vegetative Plaques on the Buttocks: Challenge.

The American Journal of dermatopathology·2024
Same author

Patient and provider-directed adjunct diagnostic tools in the detection of skin cancer.

Dermatology online journal·2024
Same author

Clinical Presentation of Atopic Dermatitis.

Advances in experimental medicine and biology·2024

Related Experiment Video

Updated: Jan 20, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

927

Systemic Therapies for Advanced Melanoma.

Leonora Bomar1, Aditi Senithilnathan1, Christine Ahn1

  • 1Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Dermatologic Clinics
|August 31, 2019
PubMed
Summary

Metastatic melanoma incidence is rising, with poor survival for advanced cases. Recent breakthroughs offer new treatment options like immunotherapy and targeted therapy for better outcomes.

Keywords:
AdvancedAnti-PD1 agentsBRAF inhibitorsChemotherapyIpilimumabMEK inhibitorsMelanomaMetastatic

More Related Videos

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

905
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

Related Experiment Videos

Last Updated: Jan 20, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

927
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

905
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Metastatic melanoma incidence is increasing globally.
  • Current treatments for localized melanoma are effective, but advanced disease survival remains poor.

Purpose of the Study:

  • To provide an overview of current treatment options for advanced melanoma.
  • To highlight recent therapeutic advancements in melanoma treatment.

Main Methods:

  • Review of existing literature on melanoma treatment.
  • Analysis of therapeutic options including chemotherapy, targeted therapy, immunotherapy, and oncolytic viral agents.

Main Results:

  • Significant progress in therapeutic options over the last two decades.
  • Emergence of immune checkpoint inhibitors, small molecule targeted therapy, and oncolytic viral therapy.

Conclusions:

  • Advanced melanoma treatment has evolved significantly.
  • New therapies offer improved outcomes for patients with metastatic melanoma.